// App-Quantinova.ai

3770 : HEXIM1 as a pharmacodynamic marker for monitoring target engagement of ABBV-075

Researchers

Presenter

  • Xiaoli Huang

Principal Investigators

  • Xiaoyu Lin

  • Leiming Li

  • Rongqi Wang

  • Lisa Roberts

  • Paul Hessler

  • Tamar Uziel

  • Lloyd Lam

  • Terry Magoc

  • Daniel H. Albert

  • Steven W. Elmore

  • Guowei Fang

  • Saul H. Rosenberg

  • Keith McDaniel

  • Warren Kati

  • Yu Shen

Medical Centers

  • AbbVie, Inc., North Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

  • Hexamethylene Bisacetamide Inducible 1

Drug/Treatment

  • abbv-075

Outcome

  • N/A

Study Design

  • Pharmacodynamics

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved